Skip to main content
Journal cover image

A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility.

Publication ,  Journal Article
Thompson, EJ; Foote, HP; Hill, KD; Hornik, CP
Published in: Contemp Clin Trials Commun
October 2023

BACKGROUND: High-quality, efficient, pharmacokinetic (PK), pharmacodynamic (PD), and safety studies in children are needed. Point-of-care trials in adults have facilitated clinical trial participation for patients and providers, minimized the disruption of clinical workflow, and capitalized on routine data collection. The feasibility and value of point-of-care trials to study PK/PD in children are unknown, but appear promising. The Opportunistic PK/PD Trial in Critically Ill Children with Heart Disease (OPTIC) is a programmatic point-of-care approach to PK/PD trials in critically ill children that seeks to overcome barriers of traditional pediatric PK/PD studies to generate safety, efficacy, PK, and PD data across multiple medications, ages, and disease processes. METHODS: This prospective, open-label, non-randomized point-of-care trial will characterize the PK/PD and safety of multiple drugs given per routine care to critically ill children with heart disease using opportunistic and scavenged biospecimen samples and data collected from the electronic health record. OPTIC has one informed consent form with drug-specific appendices, streamlining study structure and institutional review board approval. OPTIC capitalizes on routine data collection through multiple data sources that automatically capture demographics, medications, laboratory values, vital signs, flowsheets, and other clinical data. This innovative automatic data collection minimizes the burden of data collection and facilitates trial conduct. Data will be validated across sources to ensure accuracy of dataset variables. DISCUSSION: OPTIC's point-of-care trial design and automated data acquisition via the electronic health record may provide a mechanism for conducting minimal risk, minimal burden, high efficiency trials and support drug development in historically understudied patient populations. TRIAL REGISTRATION: clinicaltrials.gov number: NCT05055830. Registered on September 24, 2021.

Duke Scholars

Published In

Contemp Clin Trials Commun

DOI

EISSN

2451-8654

Publication Date

October 2023

Volume

35

Start / End Page

101182

Location

Netherlands

Related Subject Headings

  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thompson, E. J., Foote, H. P., Hill, K. D., & Hornik, C. P. (2023). A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility. Contemp Clin Trials Commun, 35, 101182. https://doi.org/10.1016/j.conctc.2023.101182
Thompson, Elizabeth J., Henry P. Foote, Kevin D. Hill, and Christoph P. Hornik. “A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility.Contemp Clin Trials Commun 35 (October 2023): 101182. https://doi.org/10.1016/j.conctc.2023.101182.
Thompson EJ, Foote HP, Hill KD, Hornik CP. A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility. Contemp Clin Trials Commun. 2023 Oct;35:101182.
Thompson, Elizabeth J., et al. “A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility.Contemp Clin Trials Commun, vol. 35, Oct. 2023, p. 101182. Pubmed, doi:10.1016/j.conctc.2023.101182.
Thompson EJ, Foote HP, Hill KD, Hornik CP. A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility. Contemp Clin Trials Commun. 2023 Oct;35:101182.
Journal cover image

Published In

Contemp Clin Trials Commun

DOI

EISSN

2451-8654

Publication Date

October 2023

Volume

35

Start / End Page

101182

Location

Netherlands

Related Subject Headings

  • 32 Biomedical and clinical sciences